Advertisement

Topics

BRIEF—£3 million investment in immunotherapy spinout

05:14 EST 15 Nov 2017 | thePharmaLetter

The CRT Pioneer Fund is investing £3 million in NeoPhore, a spin out from Cambridge, UK-based firm PhoreMost.

Original Article: BRIEF—£3 million investment in immunotherapy spinout

NEXT ARTICLE

More From BioPortfolio on "BRIEF—£3 million investment in immunotherapy spinout"

Advertisement
Quick Search
Advertisement
Advertisement